All Stories

  1. Identification of potentially anti-COVID-19 active drugs using the connectivity MAP
  2. Leukemic mitochondrial transfer generates resistance to chemotherapy
  3. Frequency and Dynamics of Leukemia-Initiating Cells during Short-term Ex Vivo Culture Informs Outcomes in Acute Myeloid Leukemia Patients
  4. The BMI1 polycomb protein represses cyclin G2-induced autophagy to support proliferation in chronic myeloid leukemia cells
  5. Essential amino acids starvation to kill leukemia
  6. Metformin: A metabolic disruptor and anti-diabetic drug to target human leukemia
  7. The metabolic perturbators metformin, phenformin and AICAR interfere with the growth and survival of murine PTEN-deficient T cell lymphomas and human T-ALL/T-LL cancer cells
  8. Pharmacological inhibition of carbonic anhydrase XII interferes with cell proliferation and induces cell apoptosis in T-cell lymphomas
  9. AS602868, a pharmacological inhibitor of IKK2, reveals the apoptotic potential of TNF-α in Jurkat leukemic cells
  10. Monitoring NF-κB Transactivation Potential Via Real-Time PCR Quantification of IκB-α Gene Expression
  11. Blocking NF-κB activation in Jurkat leukemic T cells converts the survival agent and tumor promoter PMA into an apoptotic effector
  12. Tyrosine Phosphorylation of IκB-α Activates NF-κB without Proteolytic Degradation of IκB-α
  13. Immunofluorescent quantification of tyrosine phosphorylation of cellular proteins in whole cells by flow cytometry
  14. The CD45 protein tyrosine phosphatase is required for the completion of the activation program leading to lymphokine production in the Jurkat human T cell line